VGIAX Mutual Fund Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VGIAX Analyst Rating

Moderate Buy

539 Buy

151 Hold

22 Sell

Based on the consensus analyst ratings on 712 stocks held in VGIAX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VGIAX Analyst Price Target

Average Price Target

$112.74

Based on 712 Wall Street analysts offering 12 month price targets to Vanguard Growth and Income Fund Admiral Shares holdings in the last 3 months. The average price target is $112.74 with a high forecast of $136.82 and a low forecast of $90.86. The average price target represents a 17.49% change from the last price of $95.96.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"86":"$86","137":"$137","98.75":"$98.8","111.5":"$111.5","124.25":"$124.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":136.824,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$136.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":112.744,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$112.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90.859,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.86</span>\n  </div></div>","useHTML":true}}],"tickPositions":[86,98.75,111.5,124.25,137],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,96.69,99.77723076923077,102.86446153846154,105.95169230769231,109.03892307692308,112.12615384615385,115.21338461538463,118.30061538461538,121.38784615384617,124.47507692307693,127.56230769230771,130.64953846153847,133.73676923076926,{"y":136.824,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,96.69,97.92492307692308,99.15984615384615,100.39476923076923,101.62969230769231,102.86461538461538,104.09953846153846,105.33446153846154,106.56938461538462,107.80430769230769,109.03923076923077,110.27415384615384,111.50907692307692,{"y":112.744,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,96.69,96.24146153846154,95.79292307692307,95.34438461538461,94.89584615384615,94.44730769230769,93.99876923076923,93.55023076923077,93.1016923076923,92.65315384615384,92.20461538461538,91.75607692307692,91.30753846153846,{"y":90.859,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":91.03,"date":1711929600000,"info":"<div>Price: <b>$91<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":87.06,"date":1714521600000,"info":"<div>Price: <b>$87<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":91.58,"date":1717372800000,"info":"<div>Price: <b>$92<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":95.11,"date":1719792000000,"info":"<div>Price: <b>$95<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":93.51,"date":1722470400000,"info":"<div>Price: <b>$94<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":95.06,"date":1725321600000,"info":"<div>Price: <b>$95<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":98,"date":1727740800000,"info":"<div>Price: <b>$98<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":99.05,"date":1730419200000,"info":"<div>Price: <b>$99<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":104.64,"date":1733097600000,"info":"<div>Price: <b>$105<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":101.94,"date":1735776000000,"info":"<div>Price: <b>$102<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":104.31,"date":1738540800000,"info":"<div>Price: <b>$104<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.99,"date":1740960000000,"info":"<div>Price: <b>$101<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":96.69,"date":1743465600000,"info":"<div>Price: <b>$97<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$136.82

Average Price Target$112.74

Lowest Price Target$90.86

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VGIAX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MRSN

Mersana Therapeutics

7 Buy

0 Hold

0 Sell

Strong Buy

$4.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ALXO

Alx Oncology Holdings, Inc.

4 Buy

2 Hold

0 Sell

Moderate Buy

$3.94

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RAPT

Rapt Therapeutics Inc

2 Buy

1 Hold

0 Sell

Moderate Buy

$6.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ALTO

Alto Ingredients, Inc.

2 Buy

0 Hold

0 Sell

Moderate Buy

$5.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

VIR

Vir Biotechnology, Inc.

7 Buy

1 Hold

0 Sell

Strong Buy

$33.57

VGIAX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GPRO

GoPro Inc

0 Buy

0 Hold

1 Sell

Moderate Sell

$0.30

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IPI

Intrepid Potash Inc

0 Buy

0 Hold

2 Sell

Moderate Sell

$19.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PLTR

Palantir Technologies Inc.

3 Buy

12 Hold

3 Sell

Hold

$93.69

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CPS

Cooper-Standard Holdings

0 Buy

1 Hold

0 Sell

Hold

$12.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MGEE

MGE Energy Inc

0 Buy

0 Hold

1 Sell

Moderate Sell

$75.00

VGIAX Mutual Fund FAQ

What is VGIAX’s average 12-month price target, according to analysts?

Based on analyst ratings, Vanguard Growth and Income Fund Admiral Shares’s 12-month average price target is 112.74.

What is VGIAX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for VGIAX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is VGIAX a Buy, Sell or Hold?

Vanguard Growth and Income Fund Admiral Shares has a consensus rating of Moderate Buy which is based on 539 buy ratings, 151 hold ratings and 22 sell ratings.

What is Vanguard Growth and Income Fund Admiral Shares’s price target?

The average price target for Vanguard Growth and Income Fund Admiral Shares is 112.74. This is based on 712 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $136.82 ,the lowest forecast is $90.86. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Vanguard Growth and Income Fund Admiral Shares?

Vanguard Growth and Income Fund Admiral Shares’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 712 Wall Streets Analysts.

How can I buy shares of VGIAX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing